Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cingulate Inc CING

Healthcare
Cingulate Inc. is a biopharmaceutical company. The Company is focused on the development, manufacturing, and commercialization of pharmaceutical products that utilize its precision timed release (PTR) drug delivery platform technology to create dosing schedules and drug release profiles. It focuses on the treatment of attention deficit/hyperactivity disorder (ADHD). The Company is in the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CING)

Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market

GlobeNewswire November 7, 2024

Cingulate's Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show

GlobeNewswire October 8, 2024

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

GlobeNewswire September 12, 2024

Cingulate to Participate in Benzinga All Live Access Event

GlobeNewswire August 27, 2024

Cingulate Announces Adjournment of Special Meeting

GlobeNewswire August 23, 2024

Cingulate Issued European Patent for Lead Asset CTx-1301 for the Treatment of ADHD

GlobeNewswire August 15, 2024

Cingulate Reports Second Quarter 2024 Financial Results and Provides Development Update on Major Milestones Achieved

GlobeNewswire August 13, 2024

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

GlobeNewswire June 28, 2024

Cingulate and ADHD Expert Dr. Ann Childress, MD to Participate in Benzinga All Live Access Event

GlobeNewswire June 25, 2024
View More News ››

Opinion & Analysis (NDAQ:CING)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CING)

Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301

Breaking News: $CING Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301KANSAS CITY, Kan., Sept. 12, 2024 (GLOBE NEWSWIRE...
whytestocks - September 12, 2024

CING.....Buyer beware IMHO

dump fest about to start  Last at $10.15
Iseneschal - August 26, 2024

CING....Aug 23 vote to release these warrants FYI

sec.gov/Archives/edgar/data/1862150/000149315224028947/form424b3.htm
Iseneschal - August 26, 2024

Cingulate Announces Adjournment of Special Meeting

JUST IN: $CING Cingulate Announces Adjournment of Special MeetingKANSAS CITY, Kan., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc...
whytestocks - August 23, 2024

BUY BUY BUY BUY BUY

It is not too late still regret from tuesday when it was at 2$ 
Nibinator - August 16, 2024

Cingulate Inc. (NASDAQ:CING): A Promising Biopharmaceutical

http://beyondspx.com/2024/08/01/cingulate-inc-nasdaqcing-a-promising-biopharmaceutical-company-advancing-novel-adhd-treatments/
MikeTester - August 2, 2024
View more Bullboard ››

K9 Gold Corp

K9 Gold Corp

K9 Gold Corp. is engaged in the business of identification, acquisition and exploration of mineral interests. The Company’s ...
View More »